SCHEMBL3063089

SCHEMBL3063089

CC(N)/C=C/C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6628097 1.00
SCHEMBL3063088 1.00
SCHEMBL23829876 1.00
SCHEMBL2205577 1.00
Hydrochloric Acid SCHEMBL3103866 0.97
Hydrochloric Acid SCHEMBL3088998 0.97
Hydrochloric Acid SCHEMBL3088996 0.97
Hydrochloric Acid SCHEMBL3103859 0.97
Trifluoroacetic Acid SCHEMBL3312307 0.87 GABRP (0.75)
Trifluoroacetic Acid SCHEMBL21724533 0.87 GABRP (0.75)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0995748-B1 Growth hormone secretagogues PFIZER PROD INC (US) 2004-03-31 EP claimed
US-6686359-B2 ANIMAL GROWTH REGULATORS; OSTEOPOROSIS; CONGESTIVE HEART FAILURE; MUSCULAR DISORDERS PFIZER INC. 2004-02-03 US claimed
US-20030130284-A1 Growth hormone secretagogues CARPINO PHILIP A (US) 2003-07-10 US claimed
US-6559150-B2 Neurotransmitter stimulants; antidiabetic agents; congestive heart failure; obesity; frailty; maintaining renal and catabolic homeostasis; bone fracture repair; reducing cachexia and protein loss; muscle strength and burns. PFIZER INC. 2003-05-06 US claimed
US-20020045622-A1 Growth hormone secretagogues CARPINO PHILIP A (US) 2002-04-18 US claimed
US-6358951-B1 ADMINISTERING PYRAZOLO(4,3-C)PYRIDINE DERIVATIVE TO TREAT OBESITY, CONGESTIVE HEART FAILURE, OSTEOPOROSIS, AGING, BONE AND MUSCULAR DISORDERS PFIZER INC. 2002-03-19 US claimed
EP-0995748-A1 Growth hormone secretagogues Pfizer Products Inc. (US) 2000-04-26 EP claimed
US-11998610-B2 Conjugates and methods of using the same FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2024-06-04 US disclosed
CN-106661084-B Macrocyclic broad spectrum antibiotics 阿奇克斯制药公司 2021-08-31 CN disclosed
EP-3836971-A1 CONJUGATES AND METHODS OF USING THE SAME Flagship Pioneering Innovations V, Inc. (US) 2021-06-23 EP disclosed
US-20210162057-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-06-03 US disclosed
WO-2020037009-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2020-02-20 WO disclosed
US-10273208-B2 Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods NORTHWESTERN UNIVERSITY (US) 2019-04-30 US disclosed
US-5025023-A Fungicides, antitumor agents BRISTOL-MYERS COMPANY (US) 1991-06-18 US disclosed
US-4916063-A FERMENTATION OF POLYANGIUM BRISTOL-MYERS COMPANY (US) 1990-04-10 US disclosed
US-4898940-A ANTITUMOR AGENTS BRISTOL-MYERS COMPANY (US) 1990-02-06 US disclosed
US-4833076-A ANTITUMOR AGENTS BRISTOL-MYERS COMPANY (US) 1989-05-23 US disclosed
US-4777160-A FUNGICIDES, ANTITUMOR, MICROBIOCIDES BRISTOL-MYERS (US) 1988-10-11 US disclosed
US-4692510-A ANTIBIOTICS, ANTITUMOR AGENTS BRISTOL-MYERS COMPANY (US) 1987-09-08 US disclosed
CN-86105469-A Peptide antibiotic 1987-06-10 CN disclosed